Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genotyping of BRCA1, BRCA2 and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips].

Molekuliarnaia biologiia - 1 Jan 2000

Nasedkina T V, Gromyko O E, Emel'ianova M A, Ignatova E O, Kazubskaia T P, Portnoĭ S M, Zasedatelev A S, Liubchenko L N

Abstract excerpt

Germline mutations of BRCA1/2 genes cause the predisposition of their carriers to breast or/and ovary cancers (BC or/and OC) during the lifetime. Identification of these mutations is a basis of molecular diagnosis for BC susceptibility. Rapid genotyping technique using microarrays for identificat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Checkpoint Kinase 2

Share to Genotyping Techniques

Share to Germ-Line Mutation

Share to Ovarian Neoplasms

Share to Russia

Source

Identifiers

PMID: 25850293

Genes

BRCA1
CHEK2
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25850293-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Genotyping of BRCA1, BRCA2 and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips].PMID 25850293Read ↗

[Analysis of BRCA1/2 and CHEK2 mutations in ovarian cancer and primary multiple tumors involving the ovaries. Patients of Russian population using biochips].Semantic proximity Read ↗

CHEK2 1100delC mutation is frequent among Russian breast cancer patients.Semantic proximity Read ↗

[Frequency of CHEK2 gene mutations in patients with breast cancer from the Republic of Bashkortostan].Semantic proximity Read ↗

Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers.Semantic proximity Read ↗

[Prevalence of mutations BRCA1 5382insC, and CHEK2 1100delC in the population of Siberian region].Semantic proximity Read ↗

Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.Semantic proximity Read ↗

[CHEK2-mutation in Dutch breast cancer families: expanding genetic testing for breast cancer].Semantic proximity Read ↗

Genomic large rearrangement screening of BRCA1 and BRCA2 genes in high-risk Turkish breast/ovarian cancer patients by using multiplex ligation-dependent probe amplification assay.Semantic proximity Read ↗

[Analysis of point mutations in BRCA1 gene using hybridization on hydrogel microchips].Semantic proximity Read ↗

[Infrared fluorescent markers for microarray DNA analysis on biological microchip].Semantic proximity Read ↗

[Detection of 5382insC mutation in human BRCA1 gene using fluorescent labeled oligonucleotides].Semantic proximity Read ↗

[Search for frequently encountered mutations in genes predisposing to breast cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.